New COVID-19 Vaccine Is 90 Percent Effective, Manufacturers Say

The effectiveness of the Pfizer/BioNTech vaccine, based on preliminary analysis, far exceeds expectations of experts.

09 November 2020, 12:22pmSnap

A COVID-19 vaccine being developed by Pfizer and Germany’s BioNTech has proven more than 90 percent effective in initial trials.

The companies said there were only 94 confirmed cases of the coronavirus among more than 43,500 trial participants. The success rate is far higher than expected by experts, with regulators previously saying 50 percent efficacy would justify approval of the vaccine.

Pfizer said it expects to produce up to 50 million vaccine doses globally in 2020, and up to 1.3 billion doses in 2021. In the UK, which has ordered 40 million doses of the vaccine including 10 million requested before the end of the year, those most at risk will be first in line to receive the immunisation. Care home residents and staff, and those over 75, will be vaccinated first if the manufacturers prove successful.


Pfizer and BioNTech are now applying for emergency approval in the US by the end of the month.

“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” said Dr. Albert Bourla, Pfizer Chairman and CEO.

Around a dozen vaccines are in the final stages of testing, but the Pfizer/BioNTech vaccine is the first to show results.

“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen,” Dr. Bourla added.

The pharmaceutical companies developed the vaccine independent of US government funding, announcing the results of the preliminary trials soon after Joe Biden was declared the winner of the US presidential election.

Operation Warp Speed, a US government funding programme, aimed to deliver 300 million doses of an effective vaccine by January 2021.


Health, vaccine, worldnews, world coronavirus

like this
Novavax Says Its Vaccine Is Effective Against UK COVID Variant
BioNTech Says COVID Vaccine 'Highly Likely' to Work Against New UK Strain
China’s Sinopharm Says Its COVID Vaccine Has Proved Effective
Lots of People Would Get the Vaccine Late at Night, Actually
Doctor Says Some Patients Want To Wait for an 'English' Vaccine
British Grandmother Becomes First Person in the World to Receive Pfizer COVID Vaccine
‘When I Get my Second Dose I’ll Go Wild’: Young People on Getting the Vaccine
This 14-Year-Old’s Discovery Could Lead to a Cure for COVID-19